home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Immune Molecule Fuels Tumours

  May, 24 2006 7:20
your information resource in human molecular genetics
A molecule central to chronic autoimmune diseases also promotes the incidence and growth of tumours, show Martin Oft and his colleagues in a study to be published online this week by Nature.

Doctors have suspected for more than a century that the inflammation associated with tumours also regulates their growth. Oft’s team find one such link: they show that interleukin-23 (IL-23), a cytokine already implicated in inflammatory bowel disease and other autoimmune disorders, is also central to cancer development.

The researchers show that many human tumours make excess IL-23. Blocking IL-23 in mice - using genetic engineering or an antibody - protects against carcinogens because protective T cells are better able to infiltrate transformed tissue and kill pre-cancerous cells. The results suggest that antibodies that block IL-23 might help these cytotoxic T cells invade and treat human tumours.


Martin Oft (Schering-Plough Biopharma, Palo Alto, CA, USA)
E-mail: martin.oft@spcorp.com

Abstract available online.

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.